Ligand Pharmaceuticals (LGND) Inventory Average (2011 - 2026)

Ligand Pharmaceuticals' Inventory Average history runs 16 years deep, the most recent figure standing at $11.2 million for Q1 2026.

• In Q1 2026, Inventory Average fell 22.06% year-over-year to $11.2 million; the TTM figure through Mar 2026 stood at $11.2 million (down 22.06% YoY), while the FY2025 annual figure was $11.6 million, down 38.98% from the prior year.
• Inventory Average came in at $11.2 million for Q1 2026 at Ligand Pharmaceuticals, up from $10.5 million in the prior quarter.
• In the past five years, Inventory Average ranged from a high of $26.5 million in Q1 2022 to a low of $10.5 million in Q4 2025.
• A 5-year average of $18.7 million and a median of $17.8 million in 2022 frame the typical range for Inventory Average.
• Across the five-year window, Inventory Average tumbled 48.42% in 2023 and jumped 65.93% in 2024, its largest moves.
• Ligand Pharmaceuticals' Inventory Average stood at $17.8 million in 2022, then surged by 38.58% to $24.7 million in 2023, then plunged by 37.49% to $15.4 million in 2024, then slumped by 31.85% to $10.5 million in 2025, then climbed by 6.5% to $11.2 million in 2026.
• According to Business Quant data, Inventory Average over the past three periods registered $11.2 million, $10.5 million, and $13.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison